IP Verse

Crystalline Form Of Vortioxetine Hydrobromide As Antidepressant Drug

Patent No. EP3564224 (titled "Crystalline Form Of Vortioxetine Hydrobromide As Antidepressant Drug") was filed by Dipharma Francis on Jul 17, 2015. The application was issued on Sep 29, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FRKELLYJun 29, 2022FRKELLY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3564224

DIPHARMA FRANCIS
Application Number
EP19174923A
Filing Date
Jul 17, 2015
Status
Opposition Rejected
May 3, 2024
Publication Date
Sep 29, 2021
External Links
Slate, Register , Google Patents